Bio-X
Showing 1-20 of 71 Results
-
Shamit Kachru
Professor of Physics and Director, Stanford Institute for Theoretical Physics, Emeritus
Current Research and Scholarly InterestsMy current research is focused in three directions:
— Mathematical aspects of string theory (with a focus on BPS state counts, black holes, and moonshine)
— Quantum field theory approaches to condensed matter physics (with a focus on physics of non-Fermi liquids)
— Theoretical biology, with a focus on evolution and ecology -
Joseph Kahn
Harald Trap Friis Professor
BioJoseph M. Kahn is a Professor of Electrical Engineering at Stanford University. His research addresses communication and imaging through optical fibers, including modulation, detection, signal processing and spatial multiplexing. He received A.B. and Ph.D. degrees in Physics from U.C. Berkeley in 1981 and 1986. From 1987-1990, he was at AT&T Bell Laboratories, Crawford Hill Laboratory, in Holmdel, NJ. He was on the Electrical Engineering faculty at U.C. Berkeley from 1990-2003. In 2000, he co-founded StrataLight Communications, which was acquired by Opnext, Inc. in 2009. He received the National Science Foundation Presidential Young Investigator Award in 1991 and is a Life Fellow of the IEEE.
-
A Dale Kaiser
Member, Bio-X
Current Research and Scholarly InterestsHow are genes regulated to construct a developmental program? How do signals received from other cells change the program and coordinate it for multicellular development? The approach taken by our laboratory group to answer these questions utilizes biochemistry and genetics; genetics to isolate mutants that have particular defects in development and biochemistry to determine the molecular basis of the defects. We study swarming in Myxococcus xanthus that builds fruiting bodies.
-
Anusha Kalbasi, MD
Associate Professor of Radiation Oncology (Radiation Therapy)
BioDr. Kalbasi is a physician-scientist at the Stanford Cancer Institute. In the clinic, Dr. Kalbasi is a radiation oncologist specializing in the treatment of patients with sarcoma and other solid tumors, with expertise in early phase clinical trials related to immunotherapy, cellular therapy, and radiation therapy.
The Kalbasi laboratory studies cancer immunology, with a focus on understanding—and re-engineering—the molecular conversations that immune cells have with one another and with cancer cells, especially through cytokines. By mapping how these signals are sent, received, and interpreted within immune cells and cancer cells, the lab aims to design next-generation immunotherapies that deliver the right messages at the right time—making cancer-fighting cells more potent, more persistent, and more precise. -
Julia Kaltschmidt
Professor of Neurosurgery
Current Research and Scholarly InterestsThe lab’s primary research interest is to understand how specific neuronal circuits are established. We use mouse genetics, combinatorial immunochemical labeling and high-resolution laser scanning microscopy to identify, manipulate, and quantitatively analyze synaptic contacts within the complex neuronal milieu of the spinal cord and the enteric nervous system.
-
Aya Kamaya, MD
Professor of Radiology (Body Imaging)
On Partial Leave from 03/02/2026 To 04/17/2026Current Research and Scholarly InterestsHepatobiliary imaging
Hepatocellular carcinoma
Urologic imaging
Gynecologic imaging
Thyroid imaging
Novel ultrasound technologies
Perfusion CT imaging of abdominal tumors -
Matthew Kanan
Professor of Chemistry and Senior Fellow at the Precourt Institute for Energy
BioMatt Kanan is a Professor of Chemistry and Director of the TomKat Center for Sustainable Energy at Stanford. Matt’s research group addresses challenges in energy conversion, sustainable resource utilization, and carbon dioxide removal. Their work has led to several inventions in these areas, including process technology that utilizes CO2 to streamline chemical production, metal-free CO2 hydrogenation catalysts that improve the efficiency of sustainable fuel synthesis, membrane-free electrochemical systems to generate acid and base from water, and thermochemical methods to activate silicate rocks for CO2 removal. Matt is the co-founder and Chief Scientific Advisor for ReSource Chemical Corp., an Oakland-based start-up commercializing a process created in his group to produce performance-advantaged plastics from CO2 and inedible biomass. At the TomKat Center, Matt directs programs that help Stanford students and researchers develop and commercialize innovations that impact energy and sustainability. Prior to joining the Stanford faculty in 2009, Matt did his Ph.D. studies in organic chemistry at Harvard and postdoctoral research at MIT in inorganic chemistry. He earned his B.A. in chemistry from Rice University in 2000.
-
Peter Kao
Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Current Research and Scholarly InterestsOur research program has several active projects:
1.) Pulmonary Vascular Disease Simvastatin reversed experimental pulmonary hypertension, and is safe for treatment of patients. Blinded clinical trials of efficacy are in progress.
2.) Lung inflammation and regeneration (stem cells)
3.) Lung surfactant rheology and oxidative stress
4.) Gene regulation by RNA binding proteins, NF45 and NF90 through transcriptional and posttranscriptional mechanisms -
Zerina Kapetanovic
Assistant Professor of Electrical Engineering and, by courtesy, of Computer Science and of Geophysics
BioZerina Kapetanovic is an Assistant Professor in the Department of Electrical Engineering at Stanford University working in the area of low-power wireless communication, sensing, and Internet of Things (IoT) systems. Prior to starting at Stanford, Kapetanovic was a postdoctoral researcher at Microsoft Research in the Networking Research Group and Research for Industry Group.
Kapetanovic's research has been recognized by the Yang Research Award, the Distinguished Dissertation Award from the University of Washington. She also received the Microsoft Research Distinguished Dissertation Grant and was selected to attend the 2020 UC Berkeley Rising Stars in EECS Workshop. Kapetanovic completed her PhD in Electrical Engineering from the University of Washington in 2022. -
Spyros Karadimas, MD, PhD
Assistant Professor of Neurosurgery
BioDr. Spyridon Karadimas is a board-certified, fellowship-trained cerebrovascular neurosurgeon and physician-scientist with Stanford Health Care. He is also an assistant professor in the Department of Neurosurgery at Stanford University School of Medicine.
Dr. Karadimas offers advanced, personalized treatment for complex vascular disorders of the brain, neck, and spine in both adults and children. His expertise spans brain aneurysms, arteriovenous malformations, cavernous malformations, arteriovenous fistulas, Moyamoya disease, stroke, and carotid artery disease. Dr. Karadimas is a rare combination of surgeon, scientist, and innovator dedicated to advancing patient care and shaping the future of cerebrovascular neurosurgery.
Dr. Karadimas directs a basic and translational research program focused on the neural circuits of motor control and stroke recovery. His laboratory integrates systems neuroscience, in vivo imaging, electrophysiology, and brain-computer interface development to uncover the principles of neuroplasticity, or how the brain adapts to change. This knowledge allows him to create new ways to help people move again after a brain injury.
Dr. Karadimas has published his research as first author in peer-reviewed journals such as Nature, Nature Neuroscience and Science Translational Medicine. His work has received editorial highlight at Nature Reviews Neuroscience. He has presented to his peers at international, national, and regional meetings, including those of the American Academy of Neurological Surgery, American Association of Neurological Surgeons (AANS), European Association of Neurosurgical Societies, and World Federation of Skull Base Societies.
Dr. Karadimas is a fellow of the Royal College of Surgeons of Canada and American Association of Neurological Surgeons as well as member of the Congress of Neurological Surgeons, and the North American Skull Base Society. -
Cansu Karakas
Assistant Professor of Pathology (Clinical Pathology)
BioDr. Cansu Karakas is an Assistant Professor, with subspecialty expertise in Breast Pathology. Her academic career spans notable institutions such as MD Anderson Cancer Center and (2010–2017) and NYU (2017-2018). She is passionate about research with a focus on HER2-driven breast cancers, artificial intelligence (AI) applications in breast cancer and identifying resistance mechanisms to guide novel, personalized therapeutic strategies in breast cancer.
-
Ioannis Karakikes
Associate Professor (Research) of Cardiothoracic Surgery
Current Research and Scholarly InterestsThe Karakikes Lab aims to uncover fundamental new insights into the molecular mechanisms and functional consequences of pathogenic mutations associated with familial cardiovascular diseases.
-
Hemamala Karunadasa
J.G. Jackson and C.J. Wood Professor of Chemistry and Senior Fellow at the Precourt Institute for Energy and Professor, by courtesy, of Materials Science and Engineering
BioProfessor Hema Karunadasa works with colleagues in materials science, earth science, and applied physics to drive the discovery of new materials with applications in clean energy. Using the tools of synthetic chemistry, her group designs materials that couple the structural tunability of organic molecules with the diverse electronic and optical properties of extended inorganic solids. This research targets materials such as sorbents for capturing environmental pollutants, phosphors for solid-state lighting, and absorbers for solar cells.
Hemamala Karunadasa studied chemistry and materials science at Princeton University (A.B. with high honors 2003; Certificate in Materials Science and Engineering 2003), where her undergraduate thesis project with Professor Robert J. Cava examined geometric magnetic frustration in metal oxides. She moved from solid-state chemistry to solution-state chemistry for her doctoral studies in inorganic chemistry at the University of California, Berkeley (Ph.D. 2009) with Professor Jeffrey R. Long. Her thesis focused on heavy atom building units for magnetic molecules and molecular catalysts for generating hydrogen from water. She continued to study molecular electrocatalysts for water splitting during postdoctoral research with Berkeley Professors Christopher J. Chang and Jeffrey R. Long at the Lawrence Berkeley National Lab. She further explored molecular catalysts for hydrocarbon oxidation as a postdoc at the California Institute of Technology with Professor Harry B. Gray. She joined the Stanford Chemistry Department faculty in September 2012. Her research explores solution-state routes to new solid-state materials.
Professor Karunadasa’s lab at Stanford takes a molecular approach to extended solids. Lab members gain expertise in solution- and solid-state synthetic techniques and structure determination through powder- and single-crystal x-ray diffraction. Lab tools also include a host of spectroscopic and electrochemical probes, imaging methods, and film deposition techniques. Group members further characterize their materials under extreme environments and in operating devices to tune new materials for diverse applications in renewable energy.
Please visit the lab website for more details and recent news. -
Maya M. Kasowski
Assistant Professor of Pathology, of Medicine (Pulmonary, Allergy and Critical Care Medicine) and, by courtesy, of Genetics
BioI am a clinical pathologist and assistant professor in the Departments of Medicine, Pathology, and Genetics (by courtesy) at Stanford. I completed my MD-PhD training at Yale University and my residency training and a post-doctoral fellowship in the Department of Genetics at Stanford University. My experiences as a clinical pathologist and genome scientist have made me passionate about applying cutting-edge technologies to primary patient specimens in order to characterize disease pathologies at the molecular level. The core focus of my lab is to study the mechanisms by which genetic variants influence the risk of disease through effects on intermediate molecular phenotypes.
-
Riitta Katila
W.M. Keck Professor and Professor of Management Science and Engineering
Current Research and Scholarly InterestsThe question that drives Prof. Katila's research is how technology-based firms with significant resources can stay innovative. Her work lies at the intersection of the fields of technology, innovation, and strategy and focuses on strategies that enable organizations to discover, develop and commercialize technologies. She combines theory with longitudinal large-sample data (e.g., robotics, biomedical, platform and multi-industry datasets), background fieldwork, and state-of-the-art quantitative methods. The ultimate objective is to understand what makes technology-based firms successful.
To answer this question, Prof. Katila conducts two interrelated streams of research. She studies (1) strategies that help firms leverage their existing resources (leverage stream), and (2) strategies through which firms can acquire new resources (acquisition stream) to create innovation. Her early contributions were firm centric while recent contributions focus on innovation in the context of competitive interaction and ecosystems.
Professor Katila's work has appeared in the Academy of Management Journal, Administrative Science Quarterly, Organization Science, Strategic Entrepreneurship Journal, Strategy Science, Strategic Management Journal, Research Policy and other outlets. In her work, supported by the National Science Foundation, Katila examines how firms create new products successfully. Focusing on the robotics and medical device industries, she investigates how different search approaches, such as the exploitation of existing knowledge and the exploration for new knowledge, influence the kinds of new products that technology-intensive firms introduce. -
Laurence Katznelson, MD
Professor of Neurosurgery, Emeritus
Current Research and Scholarly InterestsDr. Katznelson is an internationally known neuroendocrinologist and clinical researcher, with research expertise in the diagnosis and management of hypopituitarism, the effects of hormones on neurocognitive function, and the development of therapeutics for acromegaly and Cushings syndrome, and neuroendocrine tumors. Dr. Katznelson is the medical director of the multidisciplinary Stanford Pituitary Center, a program geared for patient management, clinical research and patient education
-
Mark A. Kay, M.D., Ph.D.
Dennis Farrey Family Professor of Pediatrics, and Professor of Genetics
Current Research and Scholarly InterestsMark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.
-
Electron Kebebew, MD, FACS
Harry A. Oberhelman, Jr. and Mark L. Welton Professor
Current Research and Scholarly InterestsDr. Kebebew’s translational and clinical investigations have three main scientific goals: 1) to develop effective therapies for fatal, rare and neglected endocrine cancers, 2) to identify new methods, strategies and technologies for improving the diagnosis and treatment of endocrine neoplasms and the prognostication of endocrine cancers, and 3) to develop methods for precision treatment of endocrine tumors.
-
Corey Keller, MD, PhD
Associate Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsThe goal of my lab is to understand the fundamental principles of human brain plasticity and build trans-diagnostic real-time monitoring platforms for personalized neurotherapeutics.
We use an array of neuroscience methods to better understand the basic principles of how to create change in brain circuits. We use this knowledge to develop more effective treatment strategies for depression and other psychiatric disorders.
